Suggested rewrite: Led a cross-functional initiative that improved [business outcome] by [measurable result], demonstrating experience relevant to this role...
Associate Medical Director, Gynecologic Oncology
Review the role, location requirements, compensation details, and application process before deciding whether this opportunity fits your next career move.
- Remote from
- USA
- Salary
- USD 188,500–235,600 / yr
- Department
- Healthcare & Medical
- Employment
- Full Time
- Experience
- Director
- Published
- Apply before
- 8 Nov 2026
- Listing views
- 51
- Application actions
- 1
Make your next move.
Prepare your resume, explore your fit, and draft a cover letter for this opportunity.
The role, at a glance.
Natera is seeking a physician leader to direct medical strategy and clinical development for cfDNA and liquid-biopsy diagnostics in gynecologic oncology. The role centers on generating clinical evidence for MRD tracking, recurrence monitoring, treatment-response assessment, and trial enrichment across gynecologic cancers. It requires collaboration with R&D, biostatistics, clinical operations, HEOR, medical affairs, commercial, regulatory, and market-access partners. The Associate Medical Director will also educate clinicians, engage key opinion leaders and cooperative groups, and represent Natera at major oncology congresses. Candidates must be board-certified physicians in gynecologic oncology or medical oncology with a substantial gynecologic oncology focus and significant clinical research experience.
Role DNA
A quick view of the complexity, pace, ownership and collaboration implied by the job description.
Pace & Pressure
5/5Autonomy Level
4/5Communication Load
5/5Salary analysis
Estimated compensation compared with the broader US market for similar roles.
Core skills
Skills and capabilities most closely associated with this opportunity.
Sample interview questions
I would begin by defining the intended-use population, clinical decision point, comparator, and meaningful outcomes such as lead time to recurrence, treatment-change impact, progression-free survival, and patient-reported outcomes. I would align the protocol with current standards of care, engage clinical investigators and statisticians early, and use a phased plan incorporating retrospective validation, prospective observational evidence, and interventional utility studies where appropriate.
I focus on the clinical question rather than the technology alone. I clearly explain the assay’s validated performance, population studied, limitations, and how results may or may not change management, using case-based discussions and transparent evidence summaries. I also invite feedback from clinicians and incorporate practical workflow considerations into education.
I would bring the discussion back to the evidence, intended use, regulatory requirements, and patient impact. I would document the areas of agreement and disagreement, seek input from medical-legal-regulatory partners, and propose language that is scientifically accurate, compliant, and clinically useful. If needed, I would escalate with a concise risk-benefit assessment and a recommended path forward.
Potential endpoints include analytical validity, clinical sensitivity and specificity, negative and positive predictive value, time from molecular detection to clinical or radiographic recurrence, correlation with progression-free and overall survival, and impact on treatment decisions. The endpoint selection should reflect the assay’s intended use and demonstrate whether testing improves clinically meaningful care rather than simply detecting disease earlier.
I would approach relationships as long-term scientific partnerships grounded in transparency, responsiveness, and shared interest in improving patient outcomes. I would listen to unmet needs, identify evidence gaps where collaboration is appropriate, establish clear governance and study objectives, and ensure that all engagements meet ethical, compliance, and publication standards.
About this role.
Advance patient care in gynecologic oncology as an Associate Medical Director at Natera. In this clinical leadership role, you will direct medical strategy and clinical development for our advanced cell-free DNA (cfDNA) and liquid biopsy portfolio, focusing on minimal residual disease (MRD) and recurrence monitoring for gynecologic malignancies (ovarian, endometrial, cervical, vulvar, and vaginal cancers). You will collaborate across research, development, commercial, and medical affairs teams to ensure the scientific rigor, clinical relevance, and clinical adoption of our molecular testing solutions.
Primary Responsibilities:
Clinical Development
Partner with the Sr. Medical Director, Oncology on the clinical development of cell-free DNA (cfDNA) molecular diagnostics and liquid biopsy assays for gynecologic cancers.
Direct the development and execution of clinical strategies and evidence-generation plans that demonstrate clinical utility in gynecologic oncology, including minimal residual disease (MRD) tracking, recurrence monitoring, treatment response assessment, and clinical trial enrichment.
Medical Education and Communication
Oversee medical education and scientific communications for healthcare providers focused on gynecologic oncology, including tumor boards, webinars, and field medical enablement.
Partner with commercial and marketing teams to deliver clear, data-driven clinical evidence and educational materials to gynecologic oncology stakeholders, including gynecologic oncology surgeons, medical oncologists, pathologists, radiation oncologists, genetic counselors, and advanced practice providers.
Representation and Advocacy
Represent Natera at medical congresses and industry events, including SGO, ASCO, and ESMO, both in person and virtually.
Build and maintain relationships with external experts, clinical investigators, cooperative groups such as NRG/GOG, and professional societies within gynecologic oncology.
Maintain a standard of scientific rigor and data-driven urgency across the oncology organization.
Research and Development
Collaborate with R&D, biostatistics, clinical operations, and HEOR on protocol development, endpoint selection, data analysis, data interpretation, peer-reviewed publications, and congress submissions in gynecologic oncology.
Support investigator-initiated research, real-world evidence generation, and clinical collaborations that advance the standard of care in gynecologic cancers.
Key Skill Sets and Responsibilities:
Gynecologic Oncology Expertise
Deep knowledge of gynecologic malignancies, including current treatment paradigms, molecular biomarkers such as HRD, MSI/Lynch, and HPV-related disease, and evolving clinical guidelines.
Provide expert medical guidance on gynecologic oncology clinical use cases, clinical trial design, and complex patient scenarios.
Comprehensive Oncology Acumen
Ability to communicate credibly across solid tumor histologies and indications to support cross-portfolio initiatives.
Stay current on advances in oncology and translate data insights into product strategy, clinical evidence, and educational content.
Cross-Disciplinary Collaboration
Work effectively with research, development, commercial, medical affairs, regulatory, market access, and legal partners to drive successful product launches and lifecycle management.
Coordinate with internal and external stakeholders to ensure clinical relevance, health-system integration, and clinical adoption of Natera’s oncology solutions.
Qualifications:
M.D. or D.O. with board certification in Gynecologic Oncology, or Medical Oncology with a significant gynecologic oncology focus, is required.
Minimum 5 years of post-training experience in oncology with a strong background in clinical research and development; clinical diagnostics or biopharma industry experience is preferred.
At least 3 years of clinical trial experience in academia, biopharma, biotech, diagnostics, or an equivalent clinical research setting.
Title and level (Associate Medical Director or Medical Director) will be commensurate with experience.
Knowledge, Skills, and Abilities:
Ability to rapidly master Natera’s core technologies and competitive landscape, communicating scientific data and clinical utility clearly to clinical and payer audiences.
Experience leading or contributing to cross-functional teams with a focus on ownership, execution, and rapid decision-making in a matrixed environment.
Excellent written and oral communication skills with strong presentation, scientific storytelling, and real-time problem-solving abilities.
Strong project leadership and organizational skills with the ability to manage multiple priorities under tight timelines.
Demonstrated ability to collaborate across functions, solve problems when structure does not exist, and resolve misalignments directly.
Working knowledge of clinical trial methodology, protocol development, regulatory and compliance frameworks, statistics, and epidemiology.
Compensation & Total Rewards
This range reflects a good-faith estimate of the base pay we reasonably expect to offer at the time of hire. Final compensation will vary based on experience, qualifications, and internal equity considerations.
This position is also eligible for additional compensation and benefits through Natera’s robust Total Rewards program, including:
Annual performance incentive bonus
Long-term equity awards
Comprehensive health benefits (medical, dental, vision)
401(k) with company match
Generous paid time off and company holidays
Additional wellness and work-life benefits
Compensation Range
$188,500—$235,600 USD
OUR OPPORTUNITY
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
The Natera team consists of highly dedicated statisticians, geneticists, doctors, laboratory scientists, business professionals, software engineers and many other professionals from world-class institutions, who care deeply for our work and each other. When you join Natera, you’ll work hard and grow quickly. Working alongside the elite of the industry, you’ll be stretched and challenged, and take pride in being part of a company that is changing the landscape of genetic disease management.
WHAT WE OFFER
Competitive Benefits – Employee benefits include comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents. Additionally, Natera employees and their immediate families receive free testing in addition to fertility care benefits. Other benefits include pregnancy and baby bonding leave, 401k benefits, commuter benefits and much more. We also offer a generous employee referral program!
For more information, visit www.natera.com.
Natera is proud to be an Equal Opportunity Employer. We are committed to ensuring a diverse and inclusive workplace environment, and welcome people of different backgrounds, experiences, abilities and perspectives. Inclusive collaboration benefits our employees, our community and our patients, and is critical to our mission of changing the management of disease worldwide.
All qualified applicants are encouraged to apply, and will be considered without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, age, veteran status, disability or any other legally protected status. We also consider qualified applicants regardless of criminal histories, consistent with applicable laws.
If you are based in California, we encourage you to read this important information for California residents.
Link: https://www.natera.com/notice-of-data-collection-california-residents/
Please be advised that Natera will reach out to candidates with a @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
For more information:
– BBB announcement on job scams
– FBI Cyber Crime resource page
This job listing has been manually reviewed by the Jobicy Trust & Safety Team for compliance with our posting guidelines, including verification of the company's legitimacy, accuracy of job details, clarity of remote work policy, and absence of misleading or fraudulent content.
Apply now.
Follow the employer’s application method and review Jobicy’s safety guidance before sharing personal information.
Continue on the employer website
Protect your personal information and never pay to secure an interview or job offer. .
